1. Home
  2. CMRC vs CTMX Comparison

CMRC vs CTMX Comparison

Compare CMRC & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMRC
  • CTMX
  • Stock Information
  • Founded
  • CMRC 2009
  • CTMX 2008
  • Country
  • CMRC United States
  • CTMX United States
  • Employees
  • CMRC N/A
  • CTMX N/A
  • Industry
  • CMRC
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMRC
  • CTMX Health Care
  • Exchange
  • CMRC Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • CMRC 391.6M
  • CTMX 380.9M
  • IPO Year
  • CMRC 2020
  • CTMX 2015
  • Fundamental
  • Price
  • CMRC $4.75
  • CTMX $2.14
  • Analyst Decision
  • CMRC Strong Buy
  • CTMX Strong Buy
  • Analyst Count
  • CMRC 1
  • CTMX 3
  • Target Price
  • CMRC $10.00
  • CTMX $5.67
  • AVG Volume (30 Days)
  • CMRC 938.5K
  • CTMX 3.9M
  • Earning Date
  • CMRC 07-31-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • CMRC N/A
  • CTMX N/A
  • EPS Growth
  • CMRC N/A
  • CTMX 263.20
  • EPS
  • CMRC N/A
  • CTMX 0.49
  • Revenue
  • CMRC $337,541,000.00
  • CTMX $141,100,000.00
  • Revenue This Year
  • CMRC $5.06
  • CTMX N/A
  • Revenue Next Year
  • CMRC $5.25
  • CTMX N/A
  • P/E Ratio
  • CMRC N/A
  • CTMX $4.24
  • Revenue Growth
  • CMRC 4.06
  • CTMX 18.01
  • 52 Week Low
  • CMRC $4.14
  • CTMX $0.40
  • 52 Week High
  • CMRC $7.99
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CMRC N/A
  • CTMX 50.30
  • Support Level
  • CMRC N/A
  • CTMX $1.89
  • Resistance Level
  • CMRC N/A
  • CTMX $2.22
  • Average True Range (ATR)
  • CMRC 0.00
  • CTMX 0.18
  • MACD
  • CMRC 0.00
  • CTMX 0.02
  • Stochastic Oscillator
  • CMRC 0.00
  • CTMX 58.62

About CMRC Commerce.com Inc. Series 1 Common Stock

Commerce.com Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of its revenue is generated from Americas-U.S.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: